Literature DB >> 8516385

Orbitotemporal neurofibromatosis: classification and treatment.

I T Jackson1, A Carbonnel, Z Potparic, K Shaw.   

Abstract

In localized orbitotemporal neurofibromatosis, the treatment depends very much on the type and severity of the orbital involvement and on the functional state of the eye. The condition can be conveniently divided into three groups, each requiring different treatment: (1) orbital soft-tissue involvement with a seeing eye, (2) orbital soft-tissue and significant bony involvement with a seeing eye, and (3) orbital soft-tissue and significant bony involvement with a blind or absent eye. A total of 24 patients with a maximum of 12 years recurrence-free follow-up are presented.

Entities:  

Mesh:

Year:  1993        PMID: 8516385     DOI: 10.1097/00006534-199307000-00001

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  14 in total

1.  Sphenoid dysplasia in neurofibromatosis type 1: a new technique for repair.

Authors:  Concezio Di Rocc; Amir Samii; Gianpiero Tamburrini; Luca Massimi; Mario Giordano
Journal:  Childs Nerv Syst       Date:  2017-04-13       Impact factor: 1.475

2.  Labial neurofibroma as the presenting feature of genital and orbitotemporal neurofibromatosis.

Authors:  Deep Dutta; Ajitesh Roy; Satinath Mukhopadhyay; Subhankar Chowdhury
Journal:  Indian J Pediatr       Date:  2013-12-29       Impact factor: 1.967

Review 3.  Ophthalmological manifestations in VHL and NF 1: pathological and diagnostic implications.

Authors:  Klaus-Martin Kreusel
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

Review 4.  Orbital/Periorbital Plexiform Neurofibromas in Children with Neurofibromatosis Type 1: Multidisciplinary Recommendations for Care.

Authors:  Robert A Avery; James A Katowitz; Michael J Fisher; Gena Heidary; Eva Dombi; Roger J Packer; Brigitte C Widemann
Journal:  Ophthalmology       Date:  2016-11-03       Impact factor: 12.079

5.  Orbitofacial neurofibromatosis: clinical characteristics and treatment outcome.

Authors:  I A Chaudhry; J Morales; F A Shamsi; W Al-Rashed; E Elzaridi; Y O Arat; C Jacquemin; D T Oystreck; T M Bosley
Journal:  Eye (Lond)       Date:  2011-12-23       Impact factor: 3.775

6.  Reconstruction of Sphenoid Wing Dysplasia with Pulsating Exophthalmos in a Case of Neurofibromatosis Type 1 Supported by Intraoperative Navigation Using a New Skull Reference System.

Authors:  Reinhard E Friedrich; Max Heiland; Uwe Kehler; Rainer Schmelzle
Journal:  Skull Base       Date:  2003-11

Review 7.  [Eye involvement in neurofibromatosis].

Authors:  M Baier; S Pitz
Journal:  Ophthalmologe       Date:  2016-05       Impact factor: 1.059

8.  Mammoth orbitofrontal neurofibromatosis with herniating meningo-encephalocele.

Authors:  Prema Dhanraj; Kingsly Paul; Shashank Lamba; Rahul Shetty
Journal:  Indian J Plast Surg       Date:  2010-01

9.  Orbitotemporal neurofibromatosis: case report.

Authors:  Mahalakshmi Balasubramanyam; Goutham Cugati; Bipasha Mukherjee
Journal:  Case Rep Ophthalmol Med       Date:  2012-03-29

10.  Initial Exploration on Temporal Branch of Facial Nerve Function Preservation in Plexiform Neurofibroma Resection.

Authors:  Xiaojie Hu; Melia Bogari; Andy Tan; Xiaoyan Gao; Yang Gao; Hui Chen; Wei Li; Yunbo Jin; Gang Ma; Xiaoxi Lin
Journal:  J Craniofac Surg       Date:  2016-09       Impact factor: 1.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.